Breakthrough infections in MPN-COVID vaccinated patients-Reference-Cited by-同舟云学术

Breakthrough infections in MPN-COVID vaccinated patients

Published:2022-11-15 Issue:11 Volume:12 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Barbui Tiziano^ORCID,Carobbio Alessandra^ORCID,Ghirardi Arianna,Iurlo Alessandra^ORCID,De Stefano Valerio^ORCID,Sobas Marta Anna,Rumi Elisa,Elli Elena Maria,Lunghi Francesca,Gasior Kabat Mercedes,Cuevas Beatriz^ORCID,Guglielmelli Paola^ORCID,Bonifacio Massimiliano^ORCID,Marchetti Monia,Alvarez-Larran Alberto,Fox Laura,Bellini Marta,Daffini Rosa,Benevolo Giulia,Carreno-Tarragona Gonzalo^ORCID,Patriarca Andrea^ORCID,Al-Ali Haifa Kathrin,Andrade-Campos Maria Marcio Miguel,Palandri Francesca^ORCID,Harrison Claire,Foncillas Maria Angeles,Osorio Santiago,Koschmieder Steffen^ORCID,Magro Mazo Elena,Kiladjian Jean-Jacques,Bolaños Calderón Estefanía,Heidel Florian H.,Quiroz Cervantes Keina^ORCID,Griesshammer Martin,Garcia-Gutierrez Valentin^ORCID,Sanchez Alberto Marin,Hernandez-Boluda Juan Carlos^ORCID,Lopez Abadia Emma,Carli Giuseppe,Sagues Serrano Miguel,Kusec Rajko,Xicoy Cirici Blanca,Guenova Margarita,Navas Elorza Begona,Angona Anna,Cichocka Edyta,Kulikowska de Nałęcz Anna,Cattaneo Daniele^ORCID,Bucelli Cristina,Betti Silvia,Borsani Oscar^ORCID,Cavalca Fabrizio,Carbonell Sara,Curto-Garcia Natalia,Benajiba Lina,Rambaldi Alessandro^ORCID,Vannucchi Alessandro Maria

Funder

Innovative Medicines Initiative

BREMBO S.p.A - COVID “3×1 project” research grant

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://www.nature.com/articles/s41408-022-00749-8.pdf

Reference14 articles.

1. Barbui T, Vannucchi AM, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021;35:485–93.

2. Barbui T, Carobbio A, Ghirardi A, Iurlo A, Sobas MA, Elli EM, et al. Determinants of early triage for hospitalization in MPN patients with COVID-19. Am J Hematol 2022. https://doi.org/10.1002/ajh.26732.

3. Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect. 2020;26:1663–9.

4. Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Carioli G, et al. Second versus first wave of COVID-19 in patients with MPN. Leukemia. 2022;36:897–900.

5. Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022;399:814–23.